Cellectis Balance Sheet Health
Financial Health criteria checks 5/6
Cellectis has a total shareholder equity of $129.4M and total debt of $44.7M, which brings its debt-to-equity ratio to 34.5%. Its total assets and total liabilities are $395.9M and $266.5M respectively.
Key information
34.5%
Debt to equity ratio
US$44.68m
Debt
| Interest coverage ratio | n/a |
| Cash | US$159.09m |
| Equity | US$129.42m |
| Total liabilities | US$266.45m |
| Total assets | US$395.88m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0WA2's short term assets ($294.4M) exceed its short term liabilities ($165.7M).
Long Term Liabilities: 0WA2's short term assets ($294.4M) exceed its long term liabilities ($100.8M).
Debt to Equity History and Analysis
Debt Level: 0WA2 has more cash than its total debt.
Reducing Debt: 0WA2's debt to equity ratio has increased from 0% to 34.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 0WA2 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 0WA2 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 14.1% per year.